Skip to main content

Isolated hypothyroxinemia linked to gestational diabetes risk

Low free thyroxine levels and isolated hypothyroxinemia, but not subclinical hypothyroidism, are associated with an increased risk for gestational diabetes.

Read more

Editor's Choice

Metabolic disorders in young people around the world

Youth-onset metabolic diseases are a major global health challenge. This review looks at variations in incidence, management and burden, epidemiology and outcomes, and the need for early prevention strategies.

Remission of type 2 diabetes: dream or reality?

Type 2 diabetes remission is increasingly recognized as an achievable goal, but what's known about the optimal therapeutic options, how remission impacts clinical outcomes, and predictors of sustained long-term remission?

Zimislecel promotes islet cell rejuvenation in type 1 diabetes

The stem cell therapy zimislecel reduces the need for exogenous insulin treatments and restores islet function in patients with type 1 diabetes.

Another promising signal for GLP-1 drugs, this time in fibromyalgia

In a large database analysis, use of GLP-1 receptor agonists was associated with a reduced symptom burden in people with fibromyalgia, but further studies with validated outcome measures are needed.

Our tailored content service will keep you up to date…

Receive newsletters curated for the busy specialist by our expert editorial team

ADA 2025: the 85th Scientific Sessions

Unlock your free and exclusive access to the latest news from the American Diabetes Association’s annual meeting.

Read more

Using CGM to optimize type 2 diabetes management with non-intensive insulin treatment in primary care

With the growing importance of primary care in diabetes, this podcast discusses the evidence on continuous glucose monitoring (CGM) use, the role of primary healthcare, and practical tips for interpreting the ambulatory glucose profile (AGP) report. 

Supported by:
  • Abbott Diabetes Care
Prof. Samuel Seidu
Developed by: Adis
Listen now
Podcast

Case Studies

Ketoacidosis in a man with type 1 diabetes treated with tirzepatide

Vigilance is key in people with type 1 diabetes who take tirzepatide. In this patient, ketoacidosis developed after malaise, aphagia, and malnutrition decreased his insulin requirements and he couldn’t manage his pump and sensor.

Sequential bilateral RAO in a diabetic patient

Metabolic disorders, like hyperlipidemia and diabetes, are high-risk factors for developing retinal artery occlusion. Timely intra-arterial thrombolysis in this case was crucial for preserving the patient's vision.

Severe neuropathic pain preceding a diagnosis of type 2 diabetes

A 51-year-old man presented with severe generalized pain. Raised HbA1c and blood glucose levels, plus findings of pre-proliferative diabetic retinopathy, led to a diagnosis of type 2 diabetes and diabetic polyneuropathy.

Episode 19: GLP-1 medicines - past, present, and future

From diabetes to obesity and beyond

In 2005 the US FDA approved the first GLP-1 medicine for type 2 diabetes, marking the start of a remarkable journey that goes beyond the stimulation of insulin secretion.

Prof. Daniel Drucker gives us a fascinating insight into the early work on GLP-1 and discusses how these medicines are impacting the lives of people with diabetes and obesity. He covers what's known about how they work, treatment duration, side effects, and the role of bariatric surgery, plus what's in the pipeline in terms of drug development and the indications that GLP-1 medicines may be used to treat in the future.

Prof. Daniel Drucker
Listen now
Podcast

Current Reviews

The Cardiovascular Burden of Gonadotropin-Releasing Hormone (GnRH) Therapy: Mechanisms, Risks, and Interventions

Gonadotropin-releasing hormone (GnRH) therapy, a cornerstone in the treatment of various oncological and reproductive conditions, has been increasingly associated with significant cardiovascular risks, particularly when administered long-term.

A Molecular Perspective on the Intricate Interplay Among Exosomes, Bioenergetic Metabolism, and the Pathogenesis of Diabetic Cardiomyopathy

Diabetic cardiomyopathy (DCM), defined as cardiac impairment resulting from the development of diabetes mellitus, has emerged as a global epidemic. DCM primarily denotes myocardial metabolic impairment induced by elevated glucose levels, with …

​​Long-Term Outcomes in Sleeve Gastrectomy versus Roux-en-Y Gastric Bypass: A Systematic Review and Meta-Analysis of Randomized Trials

Obesity is a global health concern linked to metabolic and cardiovascular complications. Bariatric surgery is an effective treatment, with sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) being the most studied procedures. This …

Keynote series | Spotlight on managing health in obesity

Obesity is a major contributor to cardiorenal metabolic disease, but its impact extends throughout the body. Understand how obesity can affect other organ systems and impact treatment, and whether weight-loss measures improve outcomes.

Prof. Eva L. Feldman
Prof. Jonette Keri
Developed by: Springer Medicine
Watch now
Video

CME & eLearning

Videos | Case Scenarios | Infographics (Link opens in a new window)

1.0 AMA PRA Category 1 Credit(s)

Refine the application of CGM technology in primary care to enhance the management of type 2 diabetes. Benefit from key updates and experiential learning using CGM devices, and practice your clinical decision-making skills.

Supported by:
  • Abbott
Developed by: Springer Health+ IME

Vodcasts | Case Scenarios (Link opens in a new window)

Expert guidance on the multidisciplinary approach to identifying and managing chronic kidney disease in patients with type 2 diabetes, plus patient scenarios to assist your decision-making and put the latest clinical guidelines into context.

This program is not available to users in the UK and US.

Supported by:
  • Novo Nordisk A/S
Developed by: Springer Health+ IME

News | Expert Reviews | Cases (Link opens in a new window)

Treating children with hormone disorders is complex and requires tailored management. To help you provide the most effective care, we deliver resources covering adrenal, thyroid, pituitary, growth, and puberty disorders, obesity, and diabetes.

Supported by:
  • Merck Healthcare KGaA, Darmstadt, Germany
Developed by: Springer Health+ IME

Further Reading

Metabolic dysfunction-associated steatotic liver disease affects the development of hepatocellular carcinoma after sustained virologic response in chronic hepatitis C patients

With the advent of direct-acting antivirals (DAAs), sustained virologic response (SVR) has become nearly universal for patients with chronic hepatitis C virus (HCV) infection [ 1 ]. The eradication of HCV not only significantly reduces the burden …

Exploring the association between gestational diabetes exposure and mental and behavioural disorders in offspring: the Finnish gestational diabetes (FinnGeDi) register-based study

Gestational diabetes mellitus (GDM) is a prevalent pregnancy-related disorder affecting 10–30% of pregnancies worldwide, and accounts for nearly 90% of diabetes cases in pregnancy [ 1 – 3 ]. It is defined as a glucose metabolism disorder detected …

Prevalence of Hepatic Steatosis and Fibrosis in Asian Indian Individuals with Type 2 Diabetes

India currently has 101 million people with diabetes, and 136 million people with prediabetes [ 1 ]. Indians develop type 2 diabetes (T2D) at younger ages and have lower levels of obesity than Western populations [ 2 – 4 ]. The incidence of new …

Selecting the Right AI Algorithm for the Job: A Guide for Navigating the AI Jungle in Ophthalmology

Artificial intelligence (AI) is transforming ophthalmology and holds great promise for improving patient care. AI algorithms have been brought to the forefront, enabling advancements in screening, diagnostics, and monitoring of ocular diseases …

Related topics

Remission of type 2 diabetes: dream or reality?

Type 2 diabetes remission is increasingly recognized as an achievable goal, but what's known about the optimal therapeutic options, how remission impacts clinical outcomes, and predictors of sustained long-term remission?

Read more

Metabolic disorders in young people around the world

Youth-onset metabolic diseases are a major global health challenge. This review looks at variations in incidence, management and burden, epidemiology and outcomes, and the need for early prevention strategies.

Read more

Ketoacidosis in a man with type 1 diabetes treated with tirzepatide

Vigilance is key in people with type 1 diabetes who take tirzepatide. In this patient, ketoacidosis developed after malaise, aphagia, and malnutrition decreased his insulin requirements and he couldn’t manage his pump and sensor.

Read more